Cell-Based Immunotherapy: The Evolving Blood Cancer Treatment Market
The management of hematological malignancies has been transformed by advances in cell-based immunotherapy, with CAR-T therapy emerging as a key treatment modality. Cell-based immunotherapy harnesses the power of the immune system to fight cancer, offering personalized treatment with the potential for durable remissions. The CAR T therapy in haematological malignancy market is...
0 Comentários 0 Compartilhamentos 5 Visualizações 0 Anterior